Preface
Revisiting radiotherapy for pancreatic cancer
Abstract
Pancreatic cancer is the eighth most common cancer diagnosed in the United States (US) yet the third deadliest. This devastating disease is estimated to become the second leading cause of cancer deaths by 2030 largely due to the high rate of occult metastatic disease and significant tumor heterogeneity, rendering unselected therapies ineffective.
